MET and cancer: Growth factor HGF/SF binds and activates MET, normal activation induces embryogenesis, while abnormal activation of MET in cancer leads rapid progression by activating multiple signaling pathways including Ras, PI3K, STAT, Wnt, and Notch signaling pathway.